Goldman Sachs
RMD icon

Goldman Sachs’s ResMed RMD Stock Holding History

Goldman Sachs’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-25,000
Closed -$2.6M – 5318
2019
Q1 		$2.6M Buy
+25,000
New +$2.58M ﹤0.01% 3445
2017
Q2 		– Sell
-1,000
Closed -$72K – 6939
2017
Q1 		$72K Sell
1,000
-500
-33% -$34.6K ﹤0.01% 6187
2016
Q4 		$93K Buy
1,500
+500
+50% +$30.6K ﹤0.01% 6176
2016
Q3 		$65K Buy
1,000
+100
+11% +$6.66K ﹤0.01% 6390
2016
Q2 		$57K Buy
900
+600
+200% +$35.4K ﹤0.01% 6382
2016
Q1 		$17K Sell
300
-2,500
-89% -$142K ﹤0.01% 6791
2015
Q4 		$150K Sell
2,800
-300
-10% -$16.9K ﹤0.01% 5911
2015
Q3 		$158K Sell
3,100
-46,400
-94% -$2.5M ﹤0.01% 6167
2015
Q2 		$2.79M Buy
49,500
+48,300
+4,025% +$3.05M ﹤0.01% 3509
2015
Q1 		$86K Sell
1,200
-400
-25% -$26K ﹤0.01% 6494
2014
Q4 		$90K Sell
1,600
-34,200
-96% -$1.79M ﹤0.01% 6609
2014
Q3 		$1.76M Buy
35,800
+1,300
+4% +$66.2K ﹤0.01% 4062
2014
Q2 		$1.75M Buy
34,500
+4,500
+15% +$223K ﹤0.01% 4133
2014
Q1 		$1.34M Sell
30,000
-10,900
-27% -$490K ﹤0.01% 4375
2013
Q4 		$1.93M Buy
+40,900
New +$2.07M ﹤0.01% 4104

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs's RMD Position: Q1 2026 in Review

Goldman Sachs increased its ResMed (RMD) stake by 2.5% in Q1 2026, buying an estimated $6.18M and bringing the position to 1,004,205 shares worth $225M. The position accounts for 0.03% of the portfolio, ranked #628.

Goldman Sachs first reported a position in RMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $236M in Q4 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Goldman Sachs held 1,004,205 shares of ResMed worth $225M as of Q1 2026.
  • Goldman Sachs bought 24,786 ResMed shares in Q1 2026, an estimated $6.18M.
  • ResMed made up 0.03% of Goldman Sachs's portfolio in Q1 2026, its #628 holding.
  • Goldman Sachs first reported a position in ResMed in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's ResMed position peaked at $236M in Q4 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.